Clinical Measurement Process
Precision Measurement & Medical Evaluation
Before initiating treatment, each patient undergoes a structured clinical measurement and validation process to ensure eligibility, safety, and therapeutic alignment.
This process ensures that treatment design is based on biological precision, immune status, and tumor-specific parameters.
The measurement process evaluates biological, clinical, and logistical parameters required for Giostar treatment eligibility.
Step 01
Medical Intake
Initial evaluation of diagnosis, medical history, and current treatment status to determine baseline eligibility.
Step 02
Biological Assessment
Analysis of immune system stability, organ function, and tumor accessibility for treatment compatibility.
Step 03
Clinical Validation
Final confirmation of eligibility, treatment feasibility, and personalized protocol design.
Core Eligibility Metrics
Immune Status
Patients must demonstrate sufficient immune system functionality to support dendritic cell activation.
Tumor Accessibility
Tumor tissue must be available via biopsy or surgical extraction for antigen profiling.
Organ Stability
Liver, kidney, and systemic function must support immunotherapy administration.
Treatment Window
Patients must be medically able to complete a structured multi-visit treatment cycle.
3
Clinical Evaluation Phases
100%
Personalized Assessment
6 Weeks
Standard Treatment Window
Begin Your Clinical Evaluation
Start the measurement process to determine eligibility for Giostar treatment.
Start Evaluation